A groundbreaking cancer vaccine, OvarianVax, is currently being developed by researchers at the University of Oxford. This potential vaccine offers new hope in the fight against ovarian cancer, a disease known for its high mortality rate and silent progression. If successful, OvarianVax could prevent ovarian cancer from developing, changing the way the disease is approached… Read More »
September 11, 2023, the U.S. Food and Drug Administration announced1 it had approved reformulated monovalent COVID shots by Pfizer and Moderna for use in individuals 12 years of age and older. They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years.2 The updated mRNA… Read More »
There were three highly unusual characteristics of the COVID vaccines: From the start, they were highly controversial and opinions on them largely split along partisan lines. Despite the previous, they were eventually mandated upon the entire population. The vaccines had an unprecedented degree of toxicity, to the point so many were injured that the majority… Read More »
In a rather shocking turn of events, the U.S. Food and Drug Administration sneaked in a “Future Framework”1 scheme that will allow Pfizer and Moderna to reformulate and release updated COVID shots without conducting any additional human clinical trials, other than what’s already been done.2,3,4 FDA Rewrites the Rules on the Fly A vote on… Read More »